NIH Research Festival
–
–
FAES Terrace
NIDDK
PHARM-4
Introduction: Lipodystrophies are rare disorders characterized by deficient adipose tissue and low endogenous leptin concentrations, leading to severe metabolic complications. Treatment with recombinant human leptin (metreleptin) significantly improves metabolic complications, especially in patients with pre-treatment endogenous leptin
Scientific Focus Area: Molecular Pharmacology
This page was last updated on Friday, March 26, 2021